24/7
Toll Free (US):
Regular US:
UK:
Our phone
国、言語、貨幣
お買物かご: ¥ 0.00 ( アイテム)
文字で検索:ABCDEFGHIJKLMNOPQRSTUVWXYZ
EmflazaEmflaza photo
Emflaza (Deflazacort)

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。

パッケージ 価格 タブレット 節約 ご注文
6mg × 180 タブレット¥ 19141.80¥ 106.34¥ 33842.47お買物かごに入れる
6mg × 120 タブレット¥ 14722.76¥ 122.69¥ 20600.09お買物かごに入れる
6mg × 90 タブレット¥ 13249.75¥ 147.22¥ 13242.39お買物かごに入れる
6mg × 60 タブレット¥ 11040.23¥ 184.00¥ 6621.19お買物かごに入れる

パッケージ 価格 タブレット 節約 ご注文
24mg × 120 タブレット
無料航空便配送
¥ 81008.35¥ 675.07¥ 14700.67お買物かごに入れる
24mg × 90 タブレット
無料航空便配送
¥ 64068.70¥ 711.87¥ 7713.06お買物かごに入れる
24mg × 60 タブレット
無料航空便配送
¥ 44183.02¥ 736.38¥ 3671.48お買物かごに入れる
24mg × 36 タブレット
無料航空便配送
¥ 27979.88¥ 777.22¥ 732.82お買物かごに入れる

パッケージ 価格 タブレット 節約 ご注文
30mg × 90 タブレット
無料航空便配送
¥ 73643.28¥ 818.26¥ 14709.88お買物かごに入れる
30mg × 60 タブレット
無料航空便配送
¥ 53021.10¥ 883.69¥ 5881.00お買物かごに入れる
30mg × 36 タブレット
無料航空便配送
¥ 33871.93¥ 940.89¥ 1469.33お買物かごに入れる
最も売れている数量。

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.